Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
People infected with HIV have a greater risk of developing cardiovascular disease than people
not infected with HIV. This may be due to increased inflammation in the blood vessels. This
study will determine whether an anti-inflammatory drug, pentoxifylline, in combination with
antiretroviral medications, is more effective at improving blood vessel function and reducing
inflammation than antiretroviral medications alone in people infected with HIV.